Skip to main content

Peer Review reports

From: Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Original Submission
1 May 2020 Submitted Original manuscript
27 Aug 2020 Author responded Author comments - Hanna Huebner
25 May 2020 Reviewed Reviewer Report
9 Jun 2020 Reviewed Reviewer Report
Resubmission - Version 2
27 Aug 2020 Submitted Manuscript version 2
30 Sep 2020 Author responded Author comments - Hanna Huebner
31 Aug 2020 Reviewed Reviewer Report
13 Sep 2020 Reviewed Reviewer Report
Resubmission - Version 3
30 Sep 2020 Submitted Manuscript version 3
15 Oct 2020 Author responded Author comments - Hanna Huebner
Resubmission - Version 4
15 Oct 2020 Submitted Manuscript version 4
Publishing
20 Oct 2020 Editorially accepted
11 Nov 2020 Article published 10.1186/s12885-020-07546-1

You can find further information about peer review here.

Back to article page
\